Inari Medical Performance
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
On a scale of 0 to 100, Inari Medical holds a performance score of 13. The company retains a Market Volatility (i.e., Beta) of -0.62, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Inari Medical are expected to decrease at a much lower rate. During the bear market, Inari Medical is likely to outperform the market. Please check Inari Medical's coefficient of variation, potential upside, day typical price, as well as the relationship between the sortino ratio and skewness , to make a quick decision on whether Inari Medical's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Inari Medical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal basic indicators, Inari Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 60.2 M |
Inari |
Inari Medical Relative Risk vs. Return Landscape
If you would invest 5,616 in Inari Medical on December 17, 2024 and sell it today you would earn a total of 2,381 from holding Inari Medical or generate 42.4% return on investment over 90 days. Inari Medical is currently generating 0.9693% in daily expected returns and assumes 5.8649% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Inari, and 81% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Inari Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inari Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inari Medical, and traders can use it to determine the average amount a Inari Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1653
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NARI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.86 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.97 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Inari Medical is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inari Medical by adding it to a well-diversified portfolio.
Inari Medical Fundamentals Growth
Inari Stock prices reflect investors' perceptions of the future prospects and financial health of Inari Medical, and Inari Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inari Stock performance.
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0321 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 4.6 B | ||||
| Shares Outstanding | 58.56 M | ||||
| Price To Earning | 275.35 X | ||||
| Price To Book | 10.77 X | ||||
| Price To Sales | 8.15 X | ||||
| Revenue | 493.63 M | ||||
| EBITDA | 15.19 M | ||||
| Cash And Equivalents | 330.5 M | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 32.05 M | ||||
| Debt To Equity | 0.07 % | ||||
| Book Value Per Share | 7.44 X | ||||
| Cash Flow From Operations | 35.93 M | ||||
| Earnings Per Share | (1.35) X | ||||
| Total Asset | 674.24 M | ||||
| Retained Earnings | (48.49 M) | ||||
About Inari Medical Performance
By evaluating Inari Medical's fundamental ratios, stakeholders can gain valuable insights into Inari Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Inari Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Inari Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people.Things to note about Inari Medical performance evaluation
Checking the ongoing alerts about Inari Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inari Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inari Medical is not yet fully synchronised with the market data | |
| Inari Medical is way too risky over 90 days horizon | |
| Inari Medical appears to be risky and price may revert if volatility continues | |
| Inari Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 498.76 M. | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment |
- Analyzing Inari Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inari Medical's stock is overvalued or undervalued compared to its peers.
- Examining Inari Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inari Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inari Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inari Medical's stock. These opinions can provide insight into Inari Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |